Document is current

Any future updates will be listed below

Confirmed 6-Month Disability Improvement and Worsening Correlate with Long-term Disability Outcomes in Alemtuzumab-Treated Patients with Multiple Sclerosis: Post Hoc Analysis of the CARE-MS Studies

Crossref DOI link: https://doi.org/10.1007/s40120-021-00262-3

Published Online: 2021-06-24

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark